STAC will work collaboratively with the company, as well as on independent initiatives, to advance new and emerging technology for science classrooms BEAVERTON, Ore., April 23, 2025 /PRNewswire ...

Agreement grants Lilly rights to employ Sangamo’s novel proprietary capsid, STAC-BBB, for up to five potential disease targets Sangamo to receive an $18 million upfront license fee and is ...

Smith topped the Southern Tier Athletic Conference with a 208 average and helped the Elmira girls to the STAC tournament title, along with Section 4 class and division championships. Smith was ...

The Student Achievement Center (StAC) – an $85 million, 138,400-square-foot building – is in its design phase and is expected to open in 2030. The facility is intended to be a hub for student ...

The agreement grants Lilly a worldwide exclusive license to utilize the STAC-BBB capsid for one initial target, with the right to add up to four additional targets after paying additional licensed ...

Sangamo’s STAC-BBB has already demonstrated potent blood-brain barrier penetration and neuronal transduction in nonhuman primates, according to the genomic medicine company. The agreement will see ...

The deal centers on Sangamo’s proprietary STAC-BBB neurotropic adeno-associated virus (AAV) capsid, designed to penetrate the blood-brain barrier and deliver genomic medicines for central ...